Presentations

Perils of polysubstance use: Tales and trends of Gabapentin. College on Problems of Drug Dependence Annual Meeting. • Black JC.

Drug abuse. Novel Aspects in Clinical Toxicology 2022. Taipai, Taiwan. November 2022. Dart RC. INVITED PRESENTATION

Not an epidemic? Controversies in substance abuse. American College of Toxicology 2022. Denver, CO. November 2022. Dart RC. KEYNOTE LECTURE

Trends within drug abuse and healthcare – COVID and beyond
Dart RC
Opioid Abuse Management Forum. San Diego, CA. July 2021. INVITED PRESENTATION

Emerging stimulant mortality trends by active ingredient
Black JC
Department of Veterans Affairs Stimulant Safety Initiative Summit. Virtual. February 2021

Web monitoring tools to monitor trends in prescription medicine misuse
Dart RC
Congress of the European Association of Poison Centres and Clinical Toxicologists Annual Conference. February 2021. INVITED PRESENTATION

The evolution of substance abuse epidemic in the US: It’s not just the drug
Dart RC
Department of Veterans Affairs Stimulant Safety Initiative Summit. Virtual. February 2021

The mosaic landscape of prescription stimulant misuse and abuse
Iwanicki JL
Department of Veterans Affairs Stimulant Safety Initiative Summit. February 2021

The mosaic landscape of prescription stimulant misuse and abuse
Iwanicki JL
Cocaine, Meth and Stimulant Summit. Virtual. November 2020

The evolution of substance abuse epidemic in the US: It’s not just the drug
Dart RC
Cocaine, Meth and Stimulant Summit. Virtual. November 2020

Emerging stimulant mortality trends by active Ingredient
Black JC
Cocaine, Meth and Stimulant Summit. Virtual. November 2020

International Conference on Opioids
Data for the opioid crisis
Dart, RC
Boston, MA. June 2019

Category 1 Focus Group Meeting
Real-world data: Do ADFs change behavior? What current opioid data imply for stimulants in the future
Iwanicki JL
Alexandria, VA. June 2019

Lisbon Addictions 2019
The mosaic approach to post-marketing surveillance
Dart RC
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Prescription drug misuse in France and Italy
Iwanicki JL
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Principles and strategies for post-marketing surveillance of prescription drugs
Iwanicki JL
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Better methods: novel methods and analyses to better understand prescription drug misuse
Schwarz J
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Prescription drug misuse in Germany
Schwarz J
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Prescription drug misuse in Spain
Torrens M
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Prescription opioid misuse in Europe: past, present and future
Torrens M
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
Prescription drug misuse in the U.K.
Wood DM
Lisbon, Portugal. October 2019

Lisbon Addictions 2019
The Future of Prescription Drug Abuse Beyond Opioids: A UK Perspective
Wood DM
Lisbon, Portugal. October 2019

Pharmacology 2019
How can we determine the issues related to prescription medicine misuse and problems in the US?
Dart RC
Edinburgh, UK. December 2019

International Conference on Opioids
Effect of abuse-deterrent formulations and immediate-release opioids on abuse, overdose and death from Rx opioids
Dart RC
Boston, MA. June 2017

College on Problems of Drug Dependence Annual Meeting
Interventions in prescription opioid abuse – do (or can) prescription monitoring programs make a difference?
Dart RC
Montreal, Quebec. June 2017

International Conference on Pharmacoepidemiology & Therapeutic Risk Management Annual Meeting
What have we learned about the impact of policies in North America?
Dart RC
Montreal, Quebec. August 2017

53rd Congress of the European Societies of Toxicology
Green JL
Trends in opioid analgesic abuse and mortality in Europe in 2017
Bratislava, Slovakia. September 2017

Saudi Psychiatric Association Meeting
Potential solutions to epidemic substance abuse in US and Europe
Dart RC
Riyadh, Saudi Arabia. October 2017

Saudi Psychiatric Association Meeting
Substance abuse in US and Europe
Dart RC
Riyadh, Saudi Arabia. October 2017

Lisbon Addictions 2017
The landscape of prescription drug misuse in the UK
Wood DM
Lisbon, Portugal. October 2017

Lisbon Addictions 2017
The European experience: prescription drug misuse in France, Germany, Italy and Spain
Green JL
Lisbon, Portugal. October 2017

Lisbon Addictions 2017
The evolution of the opioid abuse epidemic in North America
Dart RC
Lisbon, Portugal. October 2017

Human Abuse Liability & Abuse Deterrent Formulations Conference
Spotlight: New prescription drugs of abuse and their opioid interaction risks
Iwanicki JL
Bethesda, MD. November 2017

Association for Medical Education and Research in Substance Abuse Annual Meeting
Challenging my illusions about the opioid crisis
Dasgupta N
Washington, DC. November 2017

Association for Medical Education and Research in Substance Abuse Annual Meeting
The myths and realities of the opioid epidemic
Dart RC
Washington, DC. November 2017

32nd American Academy of Pain Medicine Annual Meeting
The changing landscape of prescription opioid abuse in the United States
Dart RC
Palm Springs, CA. February 2016

12th European Opiate Addiction Treatment Association Conference
RADARS System collaboration: European opioid treatment program goals and data
Green JL
Leiden, Netherlands. May 2016

XXXVI Annual International Congress of the European Association of Poisons Centres and Clinical Toxicologists
Trends in opioid analgesic abuse and mortality in Europe
Green JL
Madrid, Spain. May 2016

XXXVI Annual International Congress of the European Association of Poisons Centres and Clinical Toxicologists
Abuse Deterrent Formulations of the opioids and their relation to heroin
Dart RC
Madrid, Spain. May 2016

International Conference on Opioids
The evolution of abuse deterrent drug formulations: testing effectiveness from the benchtop to the real world
Dart RC
Boston, MA. June 2016

American Association of Pharmaceutical Scientists Annual Meeting
The evolution of abuse deterrent drug formulations: Testing effectiveness from the benchtop to the real world
Dart RC
Denver, CO. November 2016

National Academies of Sciences, Engineering, and Medicine
Post-Marketing Surveillance: Lessons Learned and Recommendations for the Future
Cicero TJ
Washington, DC. November 2016

National Academies of Sciences, Engineering, and Medicine
Opioid analgesics with abuse-deterrent properties: current data and future opportunities
Dart RC
Washington, DC. November 2016

Community Anti-Drug Coalitions of America National Leadership Forum
Innovations in Rx technology: a session on abuse deterrent formulations
Dart RC
National Harbor, MD. February 2015

American Association for the Treatment of Opioid Dependence National Conference
Emerging trends in alternative routes reported for prescription drug misuse: an international perspective
Green JL
Atlanta, GA. March 2015

Cross-Company Abuse Liability Council’s Advancements in Abuse Potential Assessments
Crowdsourcing as a way to evaluate drug abuse in the community
Dasgupta N
Bethesda, MD. April 2015

17th International Society of Addiction Medicine Annual Meeting
Falling rates of prescription opioid abuse and death in the United States: Formulations and ramifications
Iwanicki JL
Dundee, Scotland, October 2015

2014 National Rx Drug Abuse Summit
Pharmacy: Impact of Abuse-Deterrent Formulations
Dart RC
Atlanta, GA. April 2014

Canadian Pain Society 35th Annual Scientific Meeting
The Changing Landscape of Prescription Opioid Abuse and Misuse: A North American Epidemic
Dart RC
Quebec City, Quebec, Canada. May 2014

World Health Organization (WHO) Expert Committee on Drug Dependence (EDCC)
Tapentadol – Abuse and Diversion in the US (RADARS® System)
Dart RC
Geneva, Switzerland. June 2014

US Food and Drug Administration Office of Surveillance and Epidemiology Safety Seminar
Post Marketing Surveillance of Prescription Drugs – Current Data and Issues
Dart RC
Silver Spring, MD. August 2014

50th Congress of the European Societies of Toxicology
Misuse of Prescription Psychotropic Drugs, Emerging Data from Europe
Dart RC
Edinburgh, Scotland. September 2014

16th International Society of Addiction Medicine Annual Meeting
USA issues on prescription opioids
Dart RC
Yokohama, Japan. October 2014

16th International Society of Addiction Medicine Annual Meeting
Bending the curve of opioid analgesic abuse in the United States
Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Green JL
Yokohama, Japan. October 2014

Human Abuse Liability & Abuse Deterrent Formulations Conference
New Data, Directions and Product Strategies for ADFs to Prevent Initial Addiction
Dart RC
Silver Spring, MD. November 2014

FDA Drug Safety and Risk Management Advisory Committee Meeting
Prescription Drug Monitoring Programs: Evidence for Effectiveness
Lavonas E
Silver Spring, MD. January 2013

Colorado Methamphetamine Task Force
RADARS® System
Green JL
Denver, CO. February 2013

FDA Impact of Approved Drug Labeling on Chronic Opioid Therapy Part 15 Public Hearing
Impact of Approved Drug Labeling on Chronic Opioid Therapy: RADARS® System Findings
Green JL
Bethesda, MD. February 2013

FDA Psychopharmacologic Drugs Advisory Committee Meeting
Buprenorphine RADARS® System Analysis
Green JL
Silver Spring, MD. March 2013

Colorado In-State Policy Workshop, National Governors Association Policy Academy: Reducing Prescription Drug Abuse
Prescription Drug Abuse: Colorado and National Data
Lavonas EJ
Denver, CO. April 2013

Global Addiction & EUROPAD Joint Conference
Diversion, Misuse and Trafficking of Methadone and Buprenorphine
Dart RC
Pisa, Italy. May 2013

International Congress of the European Association of Poisons Centres and Clinical Toxicologists
Prescription Drugs Purchased Through the Internet: Who are the Users?
Dart RC
Copenhagen, Denmark. May 2013

College on Problems of Drug Dependence Annual Meeting
Changing Patterns of Abuse Reported to Poison Centers Following Introduction of Reformulated Extended Release Oxycodone
Dart RC
San Diego, CA. June 2013

Nurse-Physician Advisory Taskforce for Colorado Healthcare Quad-Regulator Meeting
Prescription Opioid Dependence and Addiction: Experience in the United States
Dart RC
Denver, CO. September 2013

Centers for Disease Control and Prevention (CDC) PROTECT Meeting
Root Causes, Clinical Effects, and Outcomes Of Unintentional Exposures to Buprenorphine by Young Children
Green JL
Atlanta, GA. September 2013

North American Congress of Clinical Toxicology Annual Meeting
Young Child Exposures to Prescription Medication: Do Formulation and Packaging Matter?
Lavonas EJ
Atlanta, GA. September 2013

Colloque Européen et International Toxicomanies Hépatites SIDA European Conference and International Symposium
Prescription Opioid Analgesic Dependence and Addiction: Experience in the United States
Dart RC
Biarritz, France. October 2013

Colloque Européen et International Toxicomanies Hépatites SIDA European Conference and International Symposium
Are Abuse Deterrent Formulations Effective?
Dart RC
Biarritz, France. October 2013

American Association for the Treatment of Opioid Dependence Conference
New Substances of Abuse in Europe: Results from a EUROPAD Pilot Study in Four Countries
Green JL
Philadelphia, PA. November 2013

Asia Pacific Association of Medical Toxicology International Scientific Congress
Strategies to Reduce Prescription Opioid Misuse in the USA
Green JL
Dubai, United Arab Emirates. November 2013

Pain Care Forum
RADARS® System Abuse Deterrent Formulations (ADFs) Analyses
Green JL
Washington, DC. February 2012

Drug Information Association Annual Meeting
RADARS® System: mosaic approach to opioid surveillance and REMS evaluation
Green JL
Philadelphia, PA. June 2012

College on Problems of Drug Dependence Annual Meeting
Buprenorphine-naloxone as an abuse-deterrent drug
Dart RC
Palm Springs, CA. June 2012

Pain Care Forum
Pain Care Forum – RADARS System Update
Lavonas E
Washington, DC. June 2012

Pain Care Forum
Measuring Interventions to Reduce Prescription Drug Misuse, Abuse, and Diversion
Lavonas E
Washington, DC. June 2012

California Society of Addiction Medicine Opioid Pre-Conference Workshop
RADARS® System Abuse/Tamper Deterrent Formulations
Dart RC
San Francisco, CA. September 2012

International Society of Addiction Medicine RBP Sponsored Symposium
Trends of Opioid Misuse and Diversion: Lessons for Europe from the USA
Maremanni I, Green JL
Geneva, Switzerland. October 2012

Ontario Methadone Prescribers Conference
Abuse, Misuse, and Diversion of Prescription Opioids: Evaluating the Problem and Proposed Solutions
Lavonas E
Toronto, Canada. November 2012

Abuse Liability Evaluation for Research, Treatment, and Training Working Group
Classifying abuse-related events: the RADARS® System experience
Dart RC
Washington DC. November 2012

Center for Substance Abuse Treatment. Buprenorphine Mortality - Reassessment 2010
Buprenorphine Data from The RADARS® System
Dasgupta N
Washington, DC. May 2010

Center for Substance Abuse Treatment. Methadone Mortality - Reassessment 2010
Methadone morbidity and mortality: current data and trends from the RADARS® System
Dart RC, Bailey E
Washington, DC. July 2010

Annual Pacific Drug Safety Summit
A Framework for Opioid REMS Assessment
Bogdan, G
San Francisco, CA. September 2010

Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials Meeting
Poison Center Data to Assess the Relative Abuse Rates of Prescription Opioids
Dart RC
Arlington, VA. June 2009

NJ Pain Conference
Post-Marketing Surveillance of Controlled Substance Abuse and the Emergence of REMS
Cicero TJ
September 2009

Center for Substance Abuse Treatment
RADARS® System Subutex & Suboxone: How Much is Prescribed vs. Abuse/Diversion Reports
Dasgupta N
Washington, DC. February 2008

American Society of Addiction Medicine
Buprenorphine Misuse, Abuse and Diversion in the RADARS® System
Dart RC
June 2008

National Association of State Controlled Substance Authorities Conference
Pharmacovigilance of Prescription Drugs: Misuse, Abuse and Diversion in the RADARS® System
Dart RC
October 2008

Office of National Drug Control Policy Act 109th Congress
RADARS® System
Dart RC
Washington, DC. April 2007

Center for Substance Abuse Treatment
Methadone Study
Dart RC
Washington, DC. July 2007

Center for Substance Abuse Treatment
Fentanyl Study
Dart RC
Washington, DC. August 2007